| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK690693 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.1 | 0.04 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.076 | 0.05 |
| mRNA | XMD13-2 | GDSC1000 | pan-cancer | AAC | 0.06 | 0.05 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.059 | 0.05 |
| mRNA | Docetaxel | CTRPv2 | pan-cancer | AAC | -0.093 | 0.05 |
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.064 | 0.06 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | -0.059 | 0.06 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | -0.095 | 0.06 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |